Haemonetics's (NYSE: HAE) Strong Sell recommendation was ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Trader Talk

Haemonetics (HAE) Misses Q4 EPS by 5c; Guides FY16 EPSApril 27, 2015 6:21 AM Haemonetics Reports 4th Quarter Fiscal 2015 Revenue of $226 Million and Adjusted EPS of $0.47; Full Year Revenue of $910 Million and Adjusted EPS of $1.85; Provides Fiscal 2016 GuidanceApril 27, 2015 6:00 AM